FDA approves Merck vaccine

Order byBest matchMost fresh

FDA will limit approval for seasonal COVID vaccines

Top News

Overview

Impacts

With vaccine approval process set to change, FDA advisers leave wiggle room in annual Covid-19 shot recommendations

Several of the committee members asked at Thursday’s meeting about the FDA’s new vaccine approval framework. Some expressed concern that changing the strain targeted in this year’s vaccine might decr...

· 1d · on MSN

· 3d

FDA to limit covid shot approval to 65+, those with medical conditions

· 4d · on MSN

FDA approves Novavax COVID vaccine with new conditions

Uncertainty loomed as FDA advisors met to discuss this year’s COVID shot

Expert advisors for the Food and Drug Administration met Thursday to discuss which virus strain this year's updated COVID-19 vaccines should target.

· 7h

· 1d

FDA panel recommends keeping COVID shots targeted to same strain as last year

Arizona PBS · 17h

FDA ends routine COVID shots for healthy young Americans

US FDA Advisers to Weigh Composition of COVID Vaccines for 2025-2026

Public health experts say that there is no certainty on which strains are going to be dominant.

· 1d

· 19h

COVID shots should target newer strains of JN.1 variant, US FDA advisers say

· 1d

FDA panel debates COVID vaccine recipe as questions swirl about fall shots

pharmaphorum2d

FDA okays Merck's would-be Prevnar rival Vaxneuvance

The FDA has approved a new pneumococcal vaccine from Merck & Co, just over a month after Pfizer got a green light for a new version of its market leading Prevnar shot. Merck's Vaxneuvance ...

The Washington Post9d

FDA to issue new vaccine approval guidance amid questions over coronavirus shots

Send in your questions here. End of carousel The FDA was on track to grant full approval for the vaccine April 1, according to two people familiar with the matter who spoke on the condition of ...

20hon MSN

Merck contends single dosing of Gardasil vaccine should be avoided

Despite indications that a single dose of Merck's (NYSE:MRK) human papillomavirus vaccine Gardasil could be as effective as the current multi-dosing schedule, the drugmaker said that an alternative dosing regimen should be avoided -- for now.

Trending on Bing

FDA will limit approval for seasonal COVID vaccines